This is an amended filing · View original →
SAMSUNG BIOLOGICS CO.,LTD. Rights offering price set at KRW 1,174,000 for 2,270,000 new shares
AI summary · Not investment advice
The company finalized the issue price at KRW 1,174,000 per share for 2,270,000 new shares, with payment due on November 17, 2026.
New shares · common
2,270,000 shares
Key facts
- Issue price per share
- KRW 1.2 millionFinal issue price
- Offering method
- Rights offering to existing shareholders, with unsubscribed shares offered to the general public
- Acquisition of other securities
- KRW 2.7 trillion
- New share listing date
- Nov 30, 2026
- Allotment record date
- Oct 6, 2026
- Payment date
- Nov 17, 2026
- Board resolution date
- Aug 28, 2026
- Shareholder subscription period
- Nov 9, 2026 – Nov 10, 2026
- Lead manager
- Shinhan Investment Corp., NH Investment & Securities, Korea Investment & Securities, KB Securities
Commentary
AI commentary · Not investment advice
What happened
Samsung Biologics decided to issue 2,270,000 new common shares to raise KRW 2,664.98 billion. The money will be used to acquire securities of other companies. Existing shareholders get the first right to buy. Shares they do not take up (forfeited shares) will be offered to the general public. The issue price is KRW 1,174,000 per share. Before this issue, the company had 46,290,951 common shares. The lead underwriters are Shinhan Investment, NH Investment & Securities, Korea Investment & Securities and KB Securities.
In the company's terms
Each existing share receives 0.0392737657 new shares. The record date for allocation is October 6, 2026. The right to buy new shares can be transferred to others. 20.0% is allocated first to the employee stock ownership association.
What changes for shareholders
The subscription period for existing shareholders is confirmed as November 9 to November 10, 2026. Payment is due on November 17, 2026. The new shares are scheduled to be listed on November 30, 2026. The board approved the plan on August 28, 2026.
Earlier Material Event Report filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 22.01.282022.01.28 | [Amended] Material Event Report | KRW 2.7 trillion · 36.32% of equity; based on a tender price of CHF 44.31 per share; actual amount may vary with the tender result and exchange rate |
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
S